For: | Seewoodhary J. Cytomegalovirus enterocolitis in a patient with diffuse large B-cell lymphoma after chemotherapy with rituximab. World J Gastroenterol 2006; 12(45): 7391-7391 [PMID: 17143963 DOI: 10.3748/wjg.v12.i45.7391] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i45/7391.htm |
Number | Citing Articles |
1 |
Mitsufumi Nishio, Katsuya Fujimoto, Satoshi Yamamoto, Tomoyuki Endo, Toshiya Sakai, Masato Obara, Kohki Kumano, Keisuke Yamaguchi, Yukari Takeda, Hideki Goto, Norihiro Sato, Kazuki Koizumi, Masaya Mukai, Takao Koike. Delayed redistribution of CD27, CD40 and CD80 positive B cells and the impaired in vitro immunoglobulin production in patients with non‐Hodgkin lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation. British Journal of Haematology 2007; 137(4): 349 doi: 10.1111/j.1365-2141.2007.06584.x
|
2 |
Ayad Ahmed Hussein, Eman T. Al‐Antary, Rula Najjar, Dua'a S. Al‐Hamdan, Abdulhadi Al‐Zaben, Haydar Frangoul. Incidence and risk factors for cytomegalovirus (CMV) reactivation following autologous hematopoietic stem cell transplantation in children. Pediatric Blood & Cancer 2015; 62(6): 1099 doi: 10.1002/pbc.25292
|
3 |
Matthew Rong Jie Tay, Soon Thye Lim, Miriam Tao, Richard Hong-Hui Quek, Kevin Tay, Thuan Tong Tan. Cytomegalovirus infection and end-organ disease in Asian patients with lymphoma receiving chemotherapy. Leukemia & Lymphoma 2014; 55(1): 182 doi: 10.3109/10428194.2013.798867
|
4 |
Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 2007; 16(7) doi: 10.1002/pds.1378
|